Cost-effectiveness of Lifestyle Africa: an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa

References

• Kruger HS, Venter CS, Vorster HH. Physical inactivity as a risk factor for cardiovascular disease in communities undergoing rural to urban transition: the THUSA study. Cardiovasc J S Afr. 2003;14:16–9. Epub 2003/03/07. PubMed PMID: 12621539.
   PubMedGoogle Scholar
• Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. 2001;131:871S–873S.
   PubMed Web of Science ®Google Scholar
• Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41:963–970.
   PubMed Web of Science ®Google Scholar
• Chen S, Kuhn M, Prettner K, Bloom DE. The macroeconomic burden of noncommunicable diseases in the United States: estimates and projections. PLoS One. 2018;13:e0206702.
   PubMed Web of Science ®Google Scholar
• Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pr. 2017;128:40–50.
   PubMed Web of Science ®Google Scholar
• Pheiffer C, Pillay-Van Wyk V, Joubert JD, Levitt N, Nglazi MD, Bradshaw D. The prevalence of type 2 diabetes in South Africa: a systematic review protocol. BMJ Open. 2018;8:e021029.
   PubMed Web of Science ®Google Scholar
• Schutte AE. Urgency for South Africa to prioritise cardiovascular disease management. Lancet Glob Health. 2019;7:e177–8.
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med. 2002;346:393–403.
   PubMed Web of Science ®Google Scholar
• Mash R, Kroukamp R, Gaziano T, Levitt N. Cost-effectiveness of a diabetes group education program delivered by health promoters with a guiding style in underserved communities in Cape Town, South Africa. Patient Educ Couns. 2015;98:622–626.
   PubMed Web of Science ®Google Scholar
• Sathish T, Oldenburg B, Thankappan KR, Absetz P, Shaw JE, Tapp RJ, et al. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: trial-based analysis of the Kerala Diabetes prevention program. BMC Med. 2020;18. DOI:10.1186/s12916-020-01704-9.
   PubMed Web of Science ®Google Scholar
• Catley D, Puoane T, Tsolekile L, Resnicow K, Fleming KK, Hurley EA, et al. Evaluation of an adapted version of the diabetes prevention program for low- and middle-income countries: a cluster randomized trial to evaluate “Lifestyle Africa” in South Africa. PLoS Med. 2022;19:e1003964.
   PubMed Web of Science ®Google Scholar
• Muka T, Imo D, Jaspers L, Colpani V, Chaker L, van der Lee SJ, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30:251–277.
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021.
   PubMed Web of Science ®Google Scholar
• Catley D, Puoane T, Goggin K, Tsolekile LP, Resnicow K, Fleming K, et al. Adapting the diabetes prevention program for low-and middle-income countries: preliminary implementation findings from lifestyle Africa. Transl Behav Med. 2020;10:46–54.
   PubMed Web of Science ®Google Scholar
• Catley D, Puoane T, Tsolekile L, Resnicow K, Fleming K, Hurley EA, et al. Adapting the diabetes prevention program for low and middle-income countries: protocol for a cluster randomised trial to evaluate ‘Lifestyle Africa’. BMJ Open. 2019;9:e031400.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Hoyo C, Østbye T, Hughes G, Schwartz D, Tsolekile L, et al. Determinants of obesity in an urban township of South Africa. S Afr J Clin Nutr. 2008;21:315–320.
   Google Scholar
• Statistics South Africa. Census 2011 statistical release. Pretoria, South Africa; 2012.
   Google Scholar
• Chapel JM, Wang G. Understanding cost data collection tools to improve economic evaluations of health interventions. Stroke Vasc Neurol. 2019;4:214–222.
   PubMedGoogle Scholar
• Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 2022;20:23. Epub 20220112.
   PubMed Web of Science ®Google Scholar
• Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ. Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care. 2012;35:446–454.
   PubMed Web of Science ®Google Scholar
• Bansal M, Shah M, Reilly B, Willman S, Gill M, Kaufman FR. Impact of reducing glycated hemoglobin on healthcare costs among a population with uncontrolled diabetes. Appl Health Econ Health Policy. 2018;16:675–684.
   PubMed Web of Science ®Google Scholar
• Erzse A, Stacey N, Chola L, Tugendhaft A, Freeman M, Hofman K. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study. Glob Health Action. 2019;12:1636611.
   PubMed Web of Science ®Google Scholar
• Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in low- and middle-income countries: a systematic review. BMJ Glob Health. 2019;4:e001258.
   PubMed Web of Science ®Google Scholar
• Keers JC, Groen H, Sluiter WJ, Bouma J, Links TP. Cost and benefits of a multidisciplinary intensive diabetes education programme. J Eval Clin Pract. 2005;11:293–303.
   PubMed Web of Science ®Google Scholar
• Lage MJ, Boye KS. The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database. Curr Med Res Opin. 2020;36:1441–1447.
   PubMed Web of Science ®Google Scholar
• Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017;177:1808–1817.
   PubMed Web of Science ®Google Scholar